Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Musi

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Research Square|May 10, 2023
Senolytic therapy to modulate the progression of Alzheimer's Disease (SToMP-AD) - Outcomes from the first clinical trial of senolytic therapy for Alzheimer's diseaseMitzi M Gonzales, Valentina R Garbarino, Tiffany Kautz, et al.
The New England Journal of Medicine|March 25, 2011
Pioglitazone for diabetes prevention in impaired glucose toleranceRalph A DeFronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Physiological Reports|October 1, 2025
Effects of habitual endurance and resistance exercise on insulin action in primary human skeletal muscle stem cellsPolina Krassovskaia, Filip Jevtovic, Donghai Zheng, et al.
Journal of the American Geriatrics Society|January 30, 2019
Models and Studies of Aging: Executive Summary of a Report from the U13 Conference SeriesArti Hurria, Christopher R Carpenter, Frances McFarland, et al.
The Journal of Clinical Endocrinology and Metabolism|January 21, 2015
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW studyDevjit Tripathy, Jeff E Cobb, Walter Gall, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentA Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, et al.
Nature Medicine|September 7, 2023
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trialMitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, et al.
Cell Reports|November 12, 2023
Skeletal muscle TFEB signaling promotes central nervous system function and reduces neuroinflammation during aging and neurodegenerative diseaseIan Matthews, Allison Birnbaum, Anastasia Gromova, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
A human and mouse subpopulation of senescent β-cells induces pathologic dysfunction through targetable paracrine signalingKanako Iwasaki, Priscila Carapeto, Cristian Abarca, et al.
Nature Communications|February 24, 2026
iCLAP: an innovative method for integrable co-detection of low-abundance antigens with high-plex immunostainingFan Wu, Shuyuan Zheng, Yani Chen, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Research Square|May 10, 2023
Senolytic therapy to modulate the progression of Alzheimer's Disease (SToMP-AD) - Outcomes from the first clinical trial of senolytic therapy for Alzheimer's diseaseMitzi M Gonzales, Valentina R Garbarino, Tiffany Kautz, et al.
The New England Journal of Medicine|March 25, 2011
Pioglitazone for diabetes prevention in impaired glucose toleranceRalph A DeFronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Physiological Reports|October 1, 2025
Effects of habitual endurance and resistance exercise on insulin action in primary human skeletal muscle stem cellsPolina Krassovskaia, Filip Jevtovic, Donghai Zheng, et al.
Journal of the American Geriatrics Society|January 30, 2019
Models and Studies of Aging: Executive Summary of a Report from the U13 Conference SeriesArti Hurria, Christopher R Carpenter, Frances McFarland, et al.
The Journal of Clinical Endocrinology and Metabolism|January 21, 2015
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW studyDevjit Tripathy, Jeff E Cobb, Walter Gall, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentA Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, et al.
Nature Medicine|September 7, 2023
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trialMitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, et al.
Cell Reports|November 12, 2023
Skeletal muscle TFEB signaling promotes central nervous system function and reduces neuroinflammation during aging and neurodegenerative diseaseIan Matthews, Allison Birnbaum, Anastasia Gromova, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
A human and mouse subpopulation of senescent β-cells induces pathologic dysfunction through targetable paracrine signalingKanako Iwasaki, Priscila Carapeto, Cristian Abarca, et al.
Nature Communications|February 24, 2026
iCLAP: an innovative method for integrable co-detection of low-abundance antigens with high-plex immunostainingFan Wu, Shuyuan Zheng, Yani Chen, et al.
Pageof 15